During the past decade, IRCCS Oncologico Bari, Oncologia Medica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IRCCS Oncologico Bari, Oncologia Medica" are "Ovarian Cancer" (4 trials), "Advanced Non-small Cell Lung Cancer" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "IRCCS Oncologico Bari, Oncologia Medica" in a lesser frequency.

Most popular intervention types in "IRCCS Oncologico Bari, Oncologia Medica" are "Drug" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (3 trials), "cisplatin" (2 trials), "gemcitabine" (2 trials), "paclitaxel" (2 trials) and "capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Oncologico Bari, Oncologia Medica" are 4 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Oncologico Bari, Oncologia Medica". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in IRCCS Oncologico Bari, Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Oncologico Bari, Oncologia Medica, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".